Catalyst-Free Radiometal Probe Synthesis via Strained Cyclooctyne
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The conventional Huisgen 1,3-dipolar cycloaddition reaction for radiometal-labeling of probes requires catalytic Cu(I) ions, which interfere with radiometals, making it impossible to achieve catalyst-free direct construction of radiometal-labeled probes.
Innovation Solution
A catalyst-free click chemistry method using aza-dibenzocyclooctyne ligation for assembling radiometal-labeled probes with hydrophilic linkages, such as polyethylene glycol units and sugar mimetics, allowing for rapid and efficient synthesis of radiometal-labeled cyclopeptide derivatives that maintain good binding affinity to integrin αvβ3 receptors.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional Huisgen 1,3-dipolar cycloaddition reaction is used for radiometal-labeling, then high yielding synthetic transformations can be achieved, but catalytic Cu(I) ions are required which interfere with radiometals and make the reaction impossible for direct construction of radiometal-labeled probes
Solution Approach 1:
The patent removes the Cu(I) catalyst component from the Huisgen cycloaddition reaction system, extracting the harmful element that interferes with radiometals while preserving the core azide-alkyne coupling functionality to enable direct radiometal-labeling
Solution Approach 2:
The patent modifies the reaction parameters by changing the catalyst system from Cu(I)-catalyzed to catalyst-free conditions, and adjusts the alkyne substrate to use strained cyclooctyne derivatives that react without catalyst, enabling radiometal-compatible labeling
2Object-affected harmful factors
If catalyst-free methodology is used for preparing radiometal-labeled probes, then interference with radiometals is eliminated, but conventional Huisgen 1,3-dipolar cycloaddition reaction cannot achieve this
Solution Approach 1:
The patent converts the limitation of catalyst-free conditions (which normally give slow reaction rates) into an advantage by using strained cyclooctyne substrates that provide inherent reactivity, eliminating the need for Cu(I) catalyst while maintaining efficient labeling that is compatible with radiometals
3Productivity
If rapid synthesis of radiometal-labeled probes is achieved, then productivity is improved, but conventional methods require catalysts that complicate the process
Solution Approach 1:
The patent incorporates strained cyclooctyne functionality into the probe molecule during synthesis, creating a pre-activated substrate that reacts rapidly with azides without requiring catalysts, thus achieving fast radiometal-labeling while simplifying the overall process
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables rapid and efficient synthesis of radiometal-labeled probes with excellent tumor uptake and pharmacokinetic behavior, facilitating imaging and therapy applications without the need for catalysts, and can be applied to various radiometal-labeled probes.
Implementation Method 1
The Huisgen 1,3-dipolar cycloaddition reaction, which fuses an azide and an alkyne together, and provides access to a variety of five-membered heterocycles
Implementation Method 2
Radiopharmaceuticals are radioactive drugs which can have either diagnostic or therapeutic applications
Data Source
AI summary
The present application is directed to rapid and efficient synthesis of radiometal-labeled probes, pharmaceutical compositions comprising radiometal-labeled probes, and methods of using the radiometal-labeled probes. Such radiometal-labeled probes can be used in imaging studies, such as Positron Emitting Tomography (PET) or Single Photon Emission Computed Tomography (SPECT), and therapy studies.